Is HSDB 8339 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use HSDB 8339? Is HSDB 8339 safe for nursing mother and child? Does HSDB 8339 extracts into breast milk? Does HSDB 8339 has any long term or short term side effects on infants? Can HSDB 8339 influence milk supply or can HSDB 8339 decrease milk supply in lactating mothers?
Answer by DrLact: About HSDB 8339 usage in lactation
No information is available on the clinical use of HSDB 8339 during breastfeeding. Because HSDB 8339 is more than 97% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 9.7 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during HSDB 8339 therapy.
Alternate Drugs
Doxorubicin(Dangerous)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Carboplatin(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Paclitaxel(Dangerous)
Cisplatin(Unsafe)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Fluorouracil(Dangerous)
Busulfan(Dangerous)
Docetaxel(Dangerous)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Rituximab(Low Risk)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Letrozole(Dangerous)
Mitoxantrone(Dangerous)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mercaptopurine(Safe)
Cladribine(Dangerous)
Nivolumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Ipilimumab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Cetuximab(Unsafe)
Dasatinib(Unsafe)
Gemcitabine(Dangerous)
Orlistat(Low Risk)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Nilotinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)